Several factors have been identified that contribute to this impaired angiogenic response in diabetics which include maladaptive regulation of vascular endothelial growth factor (VEGF) ligand signaling [10-12], impaired release of endothelial progenitor cells from the bone marrow [13], and defective function of the released cells [13,14]. This evidence concerns the gene VEGFA and diabetes mellitus.